Day: September 18, 2024
-
Clinical trials: Patient recruitment has begun
The ETH/PHRT-funded clinical study “RAPID 01”, which includes patients with acute myeloid leukemia (AML) who relapsed or are refractory to the initial standard of care therapy, is moving into the next phase: Soon, the first patient will be recruited. The second PHRT-funded clinical study “PROGNOSTICS”, which is investigating the treatment of metastatic, castration-resistant prostate cancer…